GM
65
2
CVX
32
-2
ADM
44
-9
CINF
41
4
UHS
43
-4
TAP
51
4
WEC
53
5
TMO
44
-2
LOW
36
2
TROW
56
6
STT
50
5
ECL
59
5
SWK
39
-10
DNB
58
2
STI
35
-5
XRX
44
3
TXN
65
-3
CA
9
-3
XYL
58
2
WFC
61
3
GM
65
2
CVX
32
-2
ADM
44
-9
CINF
41
4
UHS
43
-4
TAP
51
4
WEC
53
5
TMO
44
-2
LOW
36
2
TROW
56
6
STT
50
5
ECL
59
5
SWK
39
-10
DNB
58
2
STI
35
-5
XRX
44
3
TXN
65
-3
CA
9
-3
XYL
58
2
WFC
61
3
Financhill
Back

Ono Pharmaceutical 10K Form

Sell
44

OPHLY
Ono Pharmaceutical

Last Price:
$3.61
Seasonality Move:
1.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OPHLY News And Ratings

See the #1 stock for the next 7 days that we like better than OPHLY

OPHLY Financial Statistics

Sales & Book Value

Annual Sales: $3.2B
Cash Flow: $275.7M
Price / Cash Flow: 11.25
Annual Sales: $3.71
Price / Book: 1

Profitability

EPS (TTM): 0.23770
Net Income (TTM): $335.5M
Gross Margin: $2.2B
Return on Equity: 6.28%
Return on Assets: 4.65%

Ono Pharmaceutical Earnings Forecast

Key Ono Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for OPHLY is 69.61%.
  • The Selling, General & Administrative Expenses for OPHLY have been equal to 25.81% of Gross Profit Margin.
  • The Research & Development expenses have been 30.78% of Revenue.
  • The Interest Expense is 10.63% of Operating Income.
  • The Net Earning history of OPHLY is 10.28% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 11 years.

Ono Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OPHLY
Website: ono.co.jp

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 3.07
Quick Ratio: 2.33

Price-to-Earnings

Trailing P/E Ratio: 15.89
Forward P/E Ratio: 0

OPHLY Technical Analysis vs Fundamental Analysis

Sell
44
Ono Pharmaceutical (OPHLY) is a Sell

Is Ono Pharmaceutical a Buy or a Sell?